Cannabinoid receptor 1–Adenosine A2A receptor heteromer (CB1–A2A heteromer)

The Cannabinoid receptor 1–Adenosine A2A receptor (CB1–A2A) heteromer is a macromolecular complex formed by the physical and functional association of two distinct G protein-coupled receptors. It is predominantly expressed in the basal ganglia, particularly the striatum, and the hippocampus, where it serves as a critical integrator of adenosinergic and endocannabinoid signaling to modulate the release of neurotransmitters like glutamate and dopamine (Carriba et al., 2007; Ferré et al., 2010). This heteromer is of significant therapeutic interest because its biochemical properties differ from those of the individual CB1 and A2A receptors, allowing for highly specific pharmacological targeting of brain circuits involved in motor control and reward (Aso et al., 2019). In neurodegenerative conditions such as Parkinson's and Huntington's disease, the CB1–A2A heteromer regulates the indirect pathway of the basal ganglia, making it a target for alleviating motor symptoms and potentially providing neuroprotection (Martire et al., 2011). Furthermore, the interaction within this complex explains how certain compounds, such as cannabidiol (CBD), can mitigate the cognitive impairments induced by THC by acting through an A2A-dependent mechanism (Aso et al., 2019). Drugs targeting this heteromer, including A2A antagonists and CB1 modulators, are being explored to treat neuropsychiatric disorders and addiction while minimizing the side effects associated with non-selective receptor activation.

Other names

CB1-A2A receptor complexCB1R-A2AR heteromerCannabinoid CB1-Adenosine A2A receptor oligomerA2A-CB1 heteromer

The heteromer functions through bidirectional allosteric modulation where the activation of one protomer (e.g., A2A) can either facilitate or inhibit the signaling and ligand affinity of the partner protomer (CB1). In specific neuronal populations, heteromerization induces a switch in G-protein coupling, such as shifting from Gi/Gs to Gq-mediated signaling, thereby altering the downstream intracellular response compared to individual receptors.